The Plasminogen Activator Inhibitor-1 Gene Polymorphism in Determining the Risk of Pediatric Ischemic Stroke− Case Control and Family-Based Study
A Balcerzyk, I Żak, E Emich-Widera, I Kopyta… - …, 2011 - thieme-connect.com
Pediatric ischemic stroke, though relatively rare, remains an important medical problem
since 20− 40% of patients have recurrent strokes and 50− 85% of them suffer from long-term …
since 20− 40% of patients have recurrent strokes and 50− 85% of them suffer from long-term …
[引用][C] The Plasminogen Activator Inhibitor-1 Gene Polymorphism in Determining the Risk of Pediatric Ischemic Stroke―Case Control and Family-Based Study
A BALCERZYK, I ZAK, E EMICH-WIDERA… - …, 2011 - pascal-francis.inist.fr
The Plasminogen Activator Inhibitor-1 Gene Polymorphism in Determining the Risk of Pediatric
Ischemic Stroke ― Case Control and Family-Based Study CNRS Inist Pascal-Francis CNRS Pascal …
Ischemic Stroke ― Case Control and Family-Based Study CNRS Inist Pascal-Francis CNRS Pascal …
The plasminogen activator inhibitor-1 gene polymorphism in determining the risk of pediatric ischemic stroke--case control and family-based study
A Balcerzyk, I Żak, E Emich-Widera… - …, 2011 - pubmed.ncbi.nlm.nih.gov
Pediatric ischemic stroke, though relatively rare, remains an important medical problem
since 20-40% of patients have recurrent strokes and 50-85% of them suffer from long-term …
since 20-40% of patients have recurrent strokes and 50-85% of them suffer from long-term …
The plasminogen activator inhibitor-1 gene polymorphism in determining the risk of pediatric ischemic stroke--case control and family-based study.
A Balcerzyk, I Żak, E Emich-Widera, I Kopyta… - …, 2011 - europepmc.org
Pediatric ischemic stroke, though relatively rare, remains an important medical problem
since 20-40% of patients have recurrent strokes and 50-85% of them suffer from long-term …
since 20-40% of patients have recurrent strokes and 50-85% of them suffer from long-term …